Accelerated phase chronic myeloid leukemia: evaluation of clinical criteria as predictors of survival, major cytogenetic response and progression to blast phase

BACKGROUND: Published criteria defining the accelerated phase in chronic myeloid leukemia are heterogeneous and little is known about predictors of poor outcome. METHODS: This is a retrospective study of 139 subjects in the accelerated phase of chronic myeloid leukemia treated with imatinib at a sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Furtado, Vanessa Fiorini, Santos, Gustavo Rengel, de Carvalho, Denise Siqueira, Staziaki, Pedro Vinícius, Pasquini, Ricardo, Funke, Vaneuza Araújo Moreira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685086/
https://www.ncbi.nlm.nih.gov/pubmed/26408370
http://dx.doi.org/10.1016/j.bjhh.2015.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685086/
https://www.ncbi.nlm.nih.gov/pubmed/26408370
http://dx.doi.org/10.1016/j.bjhh.2015.07.004

Ejemplares similares